Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Izabela Lepiarz-Raba, Taufik Hidayat, Anthony J. Hannan & Ali Jawaid. (2024) Potential Alzheimer’s disease drug targets identified through microglial biology research. Expert Opinion on Drug Discovery 19:5, pages 587-602.
Read now
Read now
Articles from other publishers (6)
Sujun Jiang, Guoen Cai, Zhimin Yang, Haoyuan Shi, Huajie Zeng, Qinyong Ye, Zhiyuan Hu & Zihua Wang. (2024) Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer’s Disease. ACS Nano 18:18, pages 11753-11768.
Crossref
Crossref
Joanna Mackiewicz, Malwina Lisek & Tomasz Boczek. (2023) Targeting CaN/NFAT in Alzheimer’s brain degeneration. Frontiers in Immunology 14.
Crossref
Crossref
Kai Schlepckow, Estrella Morenas-Rodríguez, Soyon Hong & Christian Haass. (2023) Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease. The Lancet Neurology 22:11, pages 1048-1060.
Crossref
Crossref
Marina Passero, Tianhua Zhai & Zuyi Huang. (2023) Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer’s Disease. International Journal of Environmental Research and Public Health 20:13, pages 6217.
Crossref
Crossref
Gunel Ayyubova. (2023) TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment. European Journal of Neuroscience 57:4, pages 718-733.
Crossref
Crossref
Wandong Zhang. 2024. Drug Delivery and Targeting. Drug Delivery and Targeting
213
230
.